SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/D1816C7F8977E1DFC085F2FE7757B9C51610DF2AA8D2D774ACAD7523EAE064A5340390AEEC6E3EF80D8B00C13F9CE0A8>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/D1816C7F8977E1DFC085F2FE7757B9C51610DF2AA8D2D774ACAD7523EAE064A5340390AEEC6E3EF80D8B00C13F9CE0A8
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/D1816C7F8977E1DFC085F2FE7757B9C51610DF2AA8D2D774ACAD7523EAE064A5340390AEEC6E3EF80D8B00C13F9CE0A8
http://www.w3.org/2000/01/rdf-schema#comment
"the expression of RANK on Circulating Tumor Cells in metastatic breast cancer patients and that the persistence of RANK expression determines denosumab effectiveness."
xsd:string
http://purl.uniprot.org/uniprot/#_C9E1778E4DF4B621E95DA08E4F5D03A4A693FEE61024B5216C61D8B2BAFAEF157F1B054A6043639D1BBAEC0C39F71B2A
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/D1816C7F8977E1DFC085F2FE7757B9C51610DF2AA8D2D774ACAD7523EAE064A5340390AEEC6E3EF80D8B00C13F9CE0A8
http://purl.uniprot.org/uniprot/Q54A98
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D1816C7F8977E1DFC085F2FE7757B9C51610DF2AA8D2D774ACAD7523EAE064A5340390AEEC6E3EF80D8B00C13F9CE0A8
http://purl.uniprot.org/uniprot/#_Q54A98-mappedCitation-31992773
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/D1816C7F8977E1DFC085F2FE7757B9C51610DF2AA8D2D774ACAD7523EAE064A5340390AEEC6E3EF80D8B00C13F9CE0A8